Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. Azitra’s lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. ATR-04, Azitra's additional clinical program, utilizes another engineered strain of S. epidermidis for the treatment of EGFR inhibitor ("EGFRi") associated skin toxicity. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic products that includes a microbial library comprised of approximately 1,500 bacterial strains.
The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.
Company Details
- Employees
- 12
- Founded
- 2014
- Address
- 21 Business Park Dr, Branford,connecticut 06405,united States
- Phone
- (203)599-0700
- in****@****inc.com
- Industry
- Biotechnology
- Website
- azitrainc.com
- HQ
- Branford, Connecticut
Azitra Inc Questions
Azitra Inc's helpline number is (203)599-0700
Azitra Inc's website is azitrainc.com
Azitra Inc's LinkedIn profile is https://www.linkedin.com/company/azitra-inc
Azitra Inc has
12 employees.
View email and phone details for 12
employees at Azitra Inc.
Azitra Inc's industry is
Biotechnology
Azitra Inc's top competitors are
Florey Biosciences,
Carogen Corporation,
Allyx Therapeutics,
Concerto Biosciences,
Dermbiont, Inc.,
Atlasxomics Inc.,
Biohaven,
Alphina Therapeutics,
Genelux,
Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt).
Azitra Inc's support email address is info@azitrainc.com
Azitra Inc's categories are Biotechnology
Azitra Inc's founding year is 2014
